Oragenics Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on June 18, 2024. The filing addresses the status of the Company's listing on the NYSE American exchange following a prior notification of non-compliance with continued listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory listing status rather than financial performance.
Material Changes
- Compliance Plan Accepted: On June 18, 2024, NYSE American accepted the Company's plan to regain compliance with Sections 1003(a)(ii) and 1003(a)(iii) of the Company Guide.
- Plan Period: The Company has been granted a plan period extending through October 18, 2025, to achieve compliance.
- Listing Status: The common stock will remain listed on NYSE American under the symbol "OGEN" but will carry a "below compliance" indicator (designated as ".BC") during the plan period.
- Monitoring: The Company is subject to quarterly monitoring for compliance with the approved plan.
Outlook, Risks, and Contingencies
Delisting Risk: If the Company fails to regain compliance by October 18, 2025, or fails to make progress consistent with its plan, NYSE American may initiate delisting proceedings.
Operational Impact: Management states that the acceptance of the compliance plan does not affect the Company's business operations or its reporting requirements with the SEC.
Investor Verification Checklist
- Verify the specific financial or operational metrics the Company intends to improve to meet Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide.
- Monitor quarterly progress reports to ensure the Company remains on track to avoid delisting by the October 18, 2025 deadline.
- Review the press release filed as Exhibit 99.1 for additional details on the compliance strategy.
- Confirm the current trading symbol includes the ".BC" designation on the NYSE American exchange.